Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mauer, S. M.
Right arrow Articles by Steffes, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mauer, S. M.
Right arrow Articles by Steffes, M. W.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 38, Issue 4 516-523, Copyright © 1989 by American Diabetes Association


ARTICLES

Long-term study of normal kidneys transplanted into patients with type I diabetes

SM Mauer, FC Goetz, LE McHugh, DE Sutherland, J Barbosa, JS Najarian and MW Steffes
Department of Pediatrics, University of Minnesota Medical School, Minneapolis 55455.

We examined the rate of development of the lesions of diabetic nephropathy in transplanted kidneys residing for 6-14 yr in type I (insulin-dependent) diabetic kidney-allograft recipients. Although each recipient had end-stage diabetic nephropathy with his/her own kidneys, there was marked variability in the rate of development of mesangial expansion observed in the transplanted kidneys. The progression of glomerular pathology, including widening of the glomerular basement membrane and expansion of the mesangium, did not correlate significantly with several potential risk factors (e.g., donor source--cadaver or living related, histocompatibility match, age of the recipient or donor, age at onset of diabetes, duration of diabetes before renal failure, immunosuppressive drug dose, blood pressure, and severity of lesions of chronic rejection). However, there was a direct albeit imprecise relationship between the index of mesangial expansion at the final biopsy and the index of glycemic control (r = .61, P less than .01). These observations suggest that currently unknown factor(s) may modulate the progression of diabetic renal disease, even in a population that had uniformly demonstrated nephropathy risk. Our data support the hypothesis that in addition to glycemic control per se, there are risk factors intrinsic to the kidney itself.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. Chang, M. L. Caramori, R. Moriya, and M. Mauer
Having One Kidney Does Not Accelerate the Rate of Development of Diabetic Nephropathy Lesions in Type 1 Diabetic Patients
Diabetes, June 1, 2008; 57(6): 1707 - 1711.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Sawai, M. Mukoyama, K. Mori, H. Yokoi, M. Koshikawa, T. Yoshioka, R. Takeda, A. Sugawara, T. Kuwahara, M. A. Saleem, et al.
Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2472 - 2477.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Fioretto, M. Bruseghin, I. Berto, P. Gallina, E. Manzato, and M. Mussap
Renal Protection in Diabetes: Role of Glycemic Control
J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S86 - S89.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. J. Dyck, P. C. O'Brien, W. J. Litchy, C. M. Harper, C. J. Klein, and P. J. B. Dyck
Monotonicity of Nerve Tests in Diabetes: Subclinical nerve dysfunction precedes diagnosis of polyneuropathy
Diabetes Care, September 1, 2005; 28(9): 2192 - 2200.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
L. A. Orloff, M. S. Orloff, S. L. Orloff, and M. J. Orloff
Lifelong Prevention of Mesangial Enlargement by Whole Pancreas Transplantation in Rats With Diabetes Mellitus
Arch Surg, August 1, 1999; 134(8): 889 - 897.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. Fioretto, M. W. Steffes, D. E.R. Sutherland, F. C. Goetz, and M. Mauer
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
N. Engl. J. Med., July 9, 1998; 339(2): 69 - 75.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1989 by the American Diabetes Association.